Alpha Genesis operates fully integrated hybrid surgical suites designed to support some of the most complex interventional studies in preclinical research. These facilities bring together real-time imaging (fluoroscopy, angiography, ultrasound, CT, and MRI) with advanced surgical techniques, allowing for catheter-based delivery, endovascular stenting, targeted tissue infusion, and device implantation under precisely monitored conditions. Our hybrid platforms enable millimeter-level accuracy in drug and vector delivery, precise vascular access, and comprehensive therapeutic evaluation across cardiovascular, neurological, and systemic disease models. Sponsors benefit from the ability to combine interventional and open surgical procedures within a single regulated environment, reducing variability and maximizing efficiency.

 

Each study includes full perioperative support, invasive hemodynamic monitoring, biomarker analysis, and long-term follow-up to generate complete safety and efficacy profiles. With validated GLP workflows, detailed regulatory documentation, and on-staff imaging specialists, Alpha Genesis ensures that every dataset meets the rigorous standards required for IND and IDE submissions. These hybrid capabilities allow for true translational modeling of clinical workflows, accelerating the development of novel therapies and devices with unmatched precision and reproducibility.